- Home
- SBET vs ACRV Comparison
SBET vs ACRV Comparison
Compare SBET & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- ACRV
- Stock Information
- Founded
- SBET 1995
- ACRV 2018
- Country
- SBET United States
- ACRV United States
- Employees
- SBET N/A
- ACRV N/A
- Industry
- SBET Computer Software: Prepackaged Software
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- SBET Technology
- ACRV Health Care
- Exchange
- SBET Nasdaq
- ACRV Nasdaq
- Market Cap
- SBET 38.7M
- ACRV 37.0M
- IPO Year
- SBET 1997
- ACRV 2022
- Fundamental
- Price
- SBET $9.47
- ACRV $1.23
- Analyst Decision
- SBET
- ACRV Buy
- Analyst Count
- SBET 0
- ACRV 7
- Target Price
- SBET N/A
- ACRV $17.60
- AVG Volume (30 Days)
- SBET 12.6M
- ACRV 490.3K
- Earning Date
- SBET 08-14-2025
- ACRV 08-12-2025
- Dividend Yield
- SBET N/A
- ACRV N/A
- EPS Growth
- SBET N/A
- ACRV N/A
- EPS
- SBET N/A
- ACRV N/A
- Revenue
- SBET $3,428,134.00
- ACRV N/A
- Revenue This Year
- SBET N/A
- ACRV N/A
- Revenue Next Year
- SBET N/A
- ACRV N/A
- P/E Ratio
- SBET N/A
- ACRV N/A
- Revenue Growth
- SBET N/A
- ACRV N/A
- 52 Week Low
- SBET $2.26
- ACRV $1.05
- 52 Week High
- SBET $124.12
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- SBET 42.48
- ACRV 46.79
- Support Level
- SBET $9.07
- ACRV $1.15
- Resistance Level
- SBET $12.03
- ACRV $1.34
- Average True Range (ATR)
- SBET 3.25
- ACRV 0.09
- MACD
- SBET -2.02
- ACRV 0.02
- Stochastic Oscillator
- SBET 2.74
- ACRV 42.11
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.